PTCT- Ptc Therapeutics, Inc.
Ptc Therapeutics, Inc. (PTCT) has 18 insiders with recent SEC Form 4 filings, including 0 buys and 59 sells. PTCT is classified in the Biotechnology industry within the Health Care sector.
Insider Ownership
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 394.1K | $27.71M | - | |
| Dir | 163.3K | $11.48M | - | |
| CFO | 90.3K | $6.35M | - | |
| Other | 80.1K | $5.63M | - | |
| VP | 79.1K | $5.56M | - |
Activity
Buys and sells only
Transactions
10 filings · page 4
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 19, 2025 | Pauwels Eric62 | Chief Business Officer | Sale+OE | 20,508 | $77.26 | $1,584,349.85 | -2.7% | -14.6% | - | |
| Dec 18, 2025 | Pauwels Eric62 | Chief Business Officer | Sale+OE | 43,492 | $75.40 | $3,279,275.05 | -7.1% | -10.2% | - | |
| Dec 3, 2025 | Reeve Emma81 | Director | Sale+OE | 733 | $78.62 | $57,628.46 | -9.9% | -15.1% | - | |
| Dec 2, 2025 | Klein Matthew B.54 | Chief Executive Officer | Sell | 3,428 | $79.07 | $271,051.96 | -1.0% | -15.5% | - | |
| Nov 25, 2025 | Almstead Neil Gregory52 | Chief Technical Ops Officer | Sale+OE | 71,928 | $83.44 | $6,001,932.05 | -3.5% | -15.0% | - | |
| Nov 25, 2025 | Jacobson Allan Steven51 | Director | Sale+OE | 26,000 | $82.00 | $2,132,018.42 | -12.1% | -15.0% | - | |
| Nov 24, 2025 | Almstead Neil Gregory52 | Chief Technical Ops Officer | Sale+OE | 35,572 | $80.18 | $2,852,030.56 | -6.6% | -11.7% | - | |
| Nov 21, 2025 | Reeve Emma81 | Director | Sale+OE | 10,000 | $79.50 | $795,000.00 | -60.0% | -10.9% | - | |
| Nov 17, 2025 | Boulding Mark Elliott55 | Exec. VP And CLO | Sale+OE | 2,812 | $75.99 | $213,686.89 | -0.9% | -8.5% | - | |
| Nov 12, 2025 | Reeve Emma81 | Director | Sale+OE | 7,333 | $74.50 | $546,308.50 | -52.4% | -3.7% | - |